Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning.

Morsink, L M; van Doesum, J; Choi, G; Hazenberg, C L E; Biswana, A; Meppelink, F; Bungener, L B; Lambeck, A J A; Huls, G

Morsink, L M; van Doesum, J; Choi, G; Hazenberg, C L E; Biswana, A; Meppelink, F; Bungener, L B; Lambeck, A J A; Huls, G.

Morsink LM; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands. l.m.morsink@umcg.nl.
van Doesum J; University of Groningen, Groningen, the Netherlands. l.m.morsink@umcg.nl.
Choi G; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
Hazenberg CLE; University of Groningen, Groningen, the Netherlands.
Biswana A; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
Meppelink F; University of Groningen, Groningen, the Netherlands.
Bungener LB; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
Lambeck AJA; University of Groningen, Groningen, the Netherlands.
Huls G; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.

Blood Cancer J ; 12(1): 6, 2022 01 12.

Article in English | MEDLINE | ID: covidwho-1621226

Subject(s)

COVID-19 Vaccines/therapeutic use; COVID-19/prevention & control; Cyclophosphamide/therapeutic use; Hematopoietic Stem Cell Transplantation; Immunosuppressive Agents/therapeutic use; Leukemia, Myeloid, Acute/therapy; Adult; Aged; Antibody Formation; COVID-19/immunology; Female; Humans; Leukemia, Myeloid, Acute/immunology; Male; Middle Aged; Retrospective Studies; Tacrolimus/therapeutic use; Transplantation Conditioning; Transplantation, Homologous; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Cyclophosphamide / COVID-19 Vaccines / COVID-19 / Immunosuppressive Agents Type of study: Observational study Topics: Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Blood Cancer J Year: 2022 Document Type: Article Affiliation country: S41408-021-00605-1

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google